1.
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Glo...
by Troeger, Christopher
The Lancet infectious diseases, 2018, Vol.18 (11), p.1191-1210
2.
The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency
by Engelhardt, Karin R., PhD
Journal of allergy and clinical immunology, 2015, Vol.136 (2), p.402-412
3.
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
by Aaron D Springer
Oligonucleotides, 2018, Vol.28 (3), p.109
4.
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 20...
by Troeger, Christopher
The Lancet infectious diseases, 2018, Vol.18 (11), p.1211-1228
5.
Control of Human Viral Infections by Natural Killer Cells
by Jost, Stephanie
Annual review of immunology, 2013, Vol.31 (1), p.163-194
6.
Emerging virus diseases transmitted by whiteflies
by Navas-Castillo, Jesús
Annual review of phytopathology, 2011, Vol.49 (1), p.219-248
7.
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
by de Martel, Catherine, MD
The lancet oncology, 2012, Vol.13 (6), p.607-615
8.
Promising approaches for the treatment and prevention of viral respiratory illnesses
by Papadopoulos, Nikolaos G
Journal of allergy and clinical immunology, 2017, Vol.140 (4), p.921-932
9.
Programmed Necrosis in the Cross Talk of Cell Death and Inflammation
by Chan, Francis Ka-Ming
Annual review of immunology, 2015, Vol.33 (1), p.79-106
10.
Prevalence of human respiratory viruses in adults with acute respiratory tract infections in Beijing, 2005–2007
by Ren, L
Clinical microbiology and infection, 2009, Vol.15 (12), p.1146-1153
11.
Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts
by Shearer, William T., MD, PhD
Journal of allergy and clinical immunology, 2014, Vol.133 (4), p.961-966
12.
Eph Receptors and Ephrins: Therapeutic Opportunities
by Barquilla, Antonio
Annual review of pharmacology and toxicology, 2015, Vol.55 (1), p.465-487
13.
Role of viral infections in the development and exacerbation of asthma in children
by Jartti, Tuomas
Journal of allergy and clinical immunology, 2017, Vol.140 (4), p.895-906
14.
Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility
by Jayesh A Kulkarni
Oligonucleotides, 2018, Vol.28 (3), p.146
15.
Evolving models of the immunopathogenesis of T cell–mediated drug allergy: The role of host, pathogens, and drug response
by White, Katie D., MD, PhD
Journal of allergy and clinical immunology, 2015, Vol.136 (2), p.219-234
16.
Macrodomains: Structure, Function, Evolution, and Catalytic Activities
by Rack, Johannes Gregor Matthias
Annual review of biochemistry, 2016, Vol.85 (1), p.431-454
17.
Factors of Concern Regarding Zika and Other Aedes aegypti-Transmitted Viruses in the United States
by Moreno-Madriñán, Max J
Journal of medical entomology, 2017, Vol.54 (2), p.251-257
18.
Population context determines cell-to-cell variability in endocytosis and virus infection
by Liberali, Prisca
Nature (London), 2009, Vol.461 (7263), p.520-523
19.
20.
Hemophagocytic lymphohistiocytosis in 2 patients with underlying IFN-γ receptor deficiency
by Tesi, Bianca, MD
Journal of allergy and clinical immunology, 2014, Vol.135 (6), p.1638-1641.e5
